An exploratory study evaluating therapeutic and pharmacodynamic effect of morphine treatment for cancer pain

An exploratory study evaluating therapeutic and pharmacodynamic effect of morphine treatment for cancer pain - An exploratory study evaluating therapeutic and pharmacodynamic effect of morphine treatment for cancer pain

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000007018

Enrollment

100

Registered

2012-01-10

Start date

2010-07-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

cancer pain

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: *patients with Cancer pain. *Patients who is taking NSAIDs. *the case that doctor judge as suitable for morphine treatment. *written informed consent.

Exclusion criteria

Exclusion criteria: *Patient who is evaluated as inappropriate for this trial by researcher

Design outcomes

Primary

Measure	Time frame
The effect of morphine treatment, the plasma concentration of morphine and biomarkers such as cytokine and SNPS	—

Countries

Japan

Contacts

Public ContactHiromichi Matsuoka

Kinki University Faculty of Medicine Department of Medical Oncology

072-366-0221

Outcome results